The Society of Cardiovascular Computed Tomography (SCCT) and Toshiba Medical announced a new partnership dedicated to providing career development opportunities for radiology fellows and residents in the United States. Toshiba Medical’s support will allow 250 U.S.-based fellows and residents to join SCCT at no charge for one year, enhancing their early career opportunities and building their awareness of the growing contributions of cardiovascular computed tomography.
PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded top range for measurement of HDL cholesterol (HDL) to 120 mg/dL (3.1 mmol/L) for the company's PTS Panels lipid panel test strips. The PTS Panels lipid panel test strip now has a measurement range of 20 to 120 mg/dL (0.52 to 3.1 mmol/L) for HDL. Additionally, the lipid panel shelf life has increased due to the use of new test strip vials.
Following repair of abdominal aortic aneurysms (AAA), women appear to have more unfavorable outcomes than men in terms of mortality and morbidity.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
April 5, 2017 — GE Healthcare has signed an agreement with HealthTrust, a group purchasing organization headquartered in ...
This week the Centers for Medicare & Medicaid Services (CMS) convened a panel of the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) to examine which health outcomes in studies of heart failure treatment technologies should be of interest to CMS. The panel also assessed the growing challenges associated with the changing landscape of evidence generated prior to market authorizations of new and innovative technology. While MEDCAC panels do not make coverage determinations, CMS does benefit from their guidance.
A multi-center study done in the United States and Canada may have global applicability for families with children afflicted with cardiomyopathy. Findings from this large National Institutes of Health (NIH) study, which have important implications in how to treat two types of dilated cardiomyopathy in children, have been published in Circulation Heart Failure, an official journal of the American Heart Association. The paper, representing findings from nearly 100 pediatric cardiology centers, is titled “Differences in Presentation and Outcomes Between Children with Familial Dilated Cardiomyopathy and Children With Idiopathic Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry Study Group.”
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Cardiovascular Systems Inc., in partnership with the Cardiovascular Research Foundation (CRF), announced the first subject enrolled in its ECLIPSE clinical trial. The subject was treated by Richard Shlofmitz, M.D., interventional cardiologist and director of the Department of Cardiology at St. Francis Hospital, Roslyn, N.Y. Shlofmitz also treated subjects in CSI’s ORBIT II and COAST clinical studies.
The American Society of Echocardiography (ASE) and the European Association of Cardiovascular Imaging (EACVI) have released a new joint document updating guidance for how best to use echocardiography to assess the growing number of patients with aortic stenosis (AS). The paper, Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE), will appear in the April issue of the Journal of the American Society of Echocardiography (JASE).
The newest release of American College of Radiology (ACR) Appropriateness Criteria covers 230 topics with more than 1,100 clinical indications.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes memory loss or other problems with cognition or thinking, according to findings from the EBBINGHAUS study. The research from the largest, most rigorously designed study to address this issue to date was presented at the American College of Cardiology’s 66th Annual Scientific Session, March 17-19 in Washington, D.C.
https://www.dicardiology.com/content/new-protocol-henry-ford-hospital-dramatically-increases-heart-attack-survival-ratesThe influence of cardiac arrest and cardiogenic shock on outcomes of patients with ST-elevation myocardial infarction (STEMI) has not been completely studied. Researchers at the Minneapolis Heart Institute Foundation (MHIF) conducted a study to determine the incidence, characteristics and outcomes of STEMI complicated by cardiac arrest with or without cardiogenic shock.
Hospitals can dramatically increase heart attack survival rates in patients suffering cardiogenic shock by providing rapid hemodynamic support before treating the cause of a heart attack, according to a new analysis that included more than 15,000 patients across the United States.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
A new meta-analysis further supports the ability of RenalGuard Therapy to significantly reduce the incidence of acute kidney injury associated with cardiovascular interventional procedures compared to other methods of urine volume expansion. Moreover, findings from the analysis show the use of RenalGuard Therapy to be further associated with reduced risk of mortality, major adverse cardiovascular events and the need for post-procedure dialysis.
DAIC Editor Dave Fornell takes a tour of some of the interesting new technologies from the vendor booths on the expo ...
April 3, 2017 — Here is the list of the top 25 most popular pieces of content on the Diagnostic and Interventional ...